Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single‐Arm Study
ABSTRACT Background This study explored the safety and efficacy of combining radiotherapy with sintilimab in non‐small cell lung cancer (NSCLC) patients who have progressed after first or second‐line therapy. Methods In this multicenter, single‐arm trial, patients with NSCLC who had progressed after...
Saved in:
| Main Authors: | Xiaoyi Feng, Xiaoyan Liu, Hui Guan, Chunhong Chen, Feng Gao, Xiaoxing Gao, Minjiang Chen, Jing Zhao, Yan Xu, Mengzhao Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.70043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial
by: Jincheng Guo, et al.
Published: (2025-04-01) -
Fruquintinib and sintilimab plus SOX as perioperative therapy for locally resectable advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase II clinical trial
by: Xiangyu Meng, et al.
Published: (2025-07-01) -
Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
by: Genlin Lu, et al.
Published: (2025-01-01) -
Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: a Chinese healthcare system perspective
by: Cuicui Yu, et al.
Published: (2025-01-01) -
Updated overall survival data and predictive biomarkers of autologous NK cells plus Sintilimab as second-line treatment for advanced non-small cell lung cancer
by: Lin Jia, et al.
Published: (2025-05-01)